SuperworthAstrana Health EPS ASTH
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- $0.82
- Latest quarter, Q2 FY26
- $0.40
- +111% on a year earlier
- Fiscal year 2025
- $0.46
- −48% on the year before
Astrana Health's earnings per share was $0.82 over the twelve months to Jun 30, 2026, up 61% on a year earlier.
In its latest quarter, Q2 FY26, it was $0.40, up 111% on the same quarter a year before.
Over the five fiscal years to FY2025 it shrank 15% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $0.46 | −48% |
| FY2024 | $0.89 | −31% |
| FY2023 | $1.29 | +32% |
| FY2022 | $0.98 | −35% |
| FY2021 | $1.51 | +50% |
| FY2020 | $1.01 | +153% |
| FY2019 | $0.40 | +43% |
| FY2018 | $0.28 | n/a |
| FY2017 | −$0.59 | −166% |
| FY2017 | $0.89 | n/a |
| FY2016 | −$1.74 | n/a |
| FY2015 | −$0.39 | n/a |
| FY2014 | n/a | n/a |
| FY2013 | −$2.70 | n/a |
| FY2012 | −$0.20 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.40 | +111% | $0.82 | |
| Q1 FY26 | $0.29 | +107% | $0.61 | |
| Q4 FY25 | $0.12 | n/a | $0.46 | |
| Q3 FY25 | $0.01 | −97% | $0.19 | |
| Q2 FY25 | $0.19 | −53% | $0.51 | |
| Q1 FY25 | $0.14 | −55% | $0.72 | |
| Q4 FY24 | −$0.15 | −158% | $0.89 | |
| Q3 FY24 | $0.33 | −30% | $1.30 | |
| Q2 FY24 | $0.40 | +43% | $1.44 | |
| Q1 FY24 | $0.31 | +11% | $1.32 | |
| Q4 FY23 | $0.26 | n/a | $1.29 | |
| Q3 FY23 | $0.47 | −6% | $0.95 |
Against its peers
Companies in Consulting Services nearest Astrana Health's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| ASTHAstrana Health | $0.82 | +61% a year |
| ICFIICF International | $4.83 | −16% a year |
| HURNHuron Consulting | $6.67 | +16% a year |
| EXPOExponent | $2.23 | +12% a year |
| FCNFTI Consulting | $8.27 | +16% a year |
| BWMNBowman Consulting | $0.40 | −34% a year |
| GGenpact LTD | $3.37 | +12% a year |
| BAHBooz Allen Hamilton | $6.38 | −22% a year |
| HCKTHackett | $0.65 | +8% a year |
| IIIInformation Services | $0.23 | +53% a year |
| Peer median | $3.37 |
Where Astrana Health ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Astrana Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.